Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase. 2013

Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, China.

A series of novel 2-aminobenzimidazole derivatives were synthesized under microwave irradiation. Their biological activities were evaluated on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). A number of the 2-aminobenzimidazole derivatives showed good inhibitory activities to AChE and BuChE. Among them, compounds 9, 12 and 13 were found to be >25-fold more selective for BuChE than AChE. No evidence of cytotoxicity was observed by MTT assay in PC12 cells or HepG2 cells exposed to 100μM of the compounds. Molecular modeling studies indicate that the benzimidazole moiety of compounds 9, 12 and 13 forms a face-to-face π-π stacking interaction in a 'sandwich' form with the indole ring of Trp82 (4.09Å) in the active gorge, and compounds 12 and 13 form a hydrogen bond with His438 at the catalytic site of BuChE. In addition, compounds 12 and 13 fit well into the hydrophobic pocket formed by Ala328, Trp430 and Tyr332 of BuChE. Our data suggest the 2-aminobenzimidazole drugs as promising new selective inhibitors for AChE and BuChE, potentially useful to treat neurodegenerative diseases.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
June 2009, European journal of medicinal chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
May 2016, Bioorganic & medicinal chemistry letters,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
February 2016, Bioorganic chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
March 2020, Bioorganic & medicinal chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
February 2010, Bioorganic & medicinal chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
July 2013, Bioorganic & medicinal chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
July 2016, Molecules (Basel, Switzerland),
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
March 2013, Bioorganic & medicinal chemistry,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
November 2013, Archiv der Pharmazie,
Jinmei Zhu, and Chun-Feng Wu, and Xiaobing Li, and Gui-Sheng Wu, and Shan Xie, and Qian-Nan Hu, and Zixin Deng, and Michael X Zhu, and Huai-Rong Luo, and Xuechuan Hong
April 2024, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!